D-0754-2026 Class II Ongoing
FDA drug recall D-0754-2026 was initiated by Apollo Care, LLC on Jul 29, 2026 and is designated Class II. Reason for recall: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material The recall status is ongoing. Affected quantity: 250 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 19, 2026
- Initiation Date
- Jul 29, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 250 vials.
Product Description
SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03
Reason for Recall
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Distribution Pattern
Nationwide within the U.S
Code Information
Lot: AC-017272, Exp. 12/12/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0754-2026
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026